Support & Resources

+1

CF®488A Annexin V and PI Apoptosis Kit

This kit contains CF®488A Annexin V to stain apoptotic cells and Propidium Iodide (PI) to stain necrotic cells.

Product Attributes

Apoptosis/viability marker

Phosphatidylserine/Annexin V, Dead cell stain, Apoptosis/necrosis assay

For live or fixed cells

For live/intact cells

Detection method/readout

Fluorescence microscopy, Flow cytometry

Assay type/options

Endpoint assay

Colors

Green/Red

Product origin

Annexin V (human); recombinant, produced in E. coli

Size
Catalog #
price
Qty
100 assays
Clear selection
Add to wishlist
ADD TO CART
(Please select quantity above )

Wishlist updated! View wishlist

Shipping, Handling & Tax (CA only) not included in price. Learn more

Tax is assessed in the state of California. All fees will be calculated during checkout based on your shipping information and are subject to change.

SPECIAL - Order 5 or more and receive 10% off.

Request a Bulk Quote

Product Description

Phosphatidylserine (PS) is translocated from the inner to the outer surface of the cell for phagocytic cell recognition. The human anticoagulant, Annexin V, is a 35 kDa Ca2+-dependent phospholipid protein with a high affinity for PS. Annexin V labeled with CF®488A (Abs/Em= 490/515 nm) can identify apoptotic cells in green by binding to PS exposed on the outer leaflet. Our CF®488A dye is superior to fluorescein/FITC as it is not affected by pH and has much better photostability. Propidium iodide (PI) is impermeant to live cells or early apoptotic cells, but stains necrotic cells and late apoptotic cells with red fluorescence (Abs/Em with DNA = 535/617 nm). Both PI and CF®488A Annexin V can be excited using the 488 nm flow cytometry laser line.

Kit Components:

  • CF®488A Annexin V (human; recombinant, produced in E. coli)
  • Propidium Iodide (PI)
  • 5X Annexin Binding Buffer

References

1. Cell Death and Disease (2014), doi:10.1038/cddis.2013.550

2. Autophagy (2016), doi: 10.1080/15548627.2016.1147667

3. J Young Pharm. (2016), doi: 10.5530/jyp.2016.3.4

4. Molecular Medicine Reports (2017), doi: 10.3892/mmr.2017.6480

 

You may also like…